About: Thomas Klimkait

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Thomas Klimkait Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) ikertzailea (eu) researcher (en) araştırmacı (tr) wetenschapper (nl) дослідник (uk) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy)
rdfs:label	Thomas Klimkait (en) Thomas Klimkait (nl) Thomas Klimkait (ast)
skos:prefLabel	Thomas Klimkait (en) Thomas Klimkait (nl) Thomas Klimkait (ast)
name	Thomas Klimkait (en) Thomas Klimkait (nl) Thomas Klimkait (ast)
Scopus author ID	wds:Q63111795-A0D83D8B-9AF5-4177-A8C3-62447334A314
Scopus author ID	7005960625
given name	wds:Q63111795-0262B525-199D-4B85-86DA-674E04CE4116
given name	Thomas
instance of	wds:Q63111795-03B0A804-17E7-4806-BD13-3BA735D81C76
instance of	Homo sapiens
occupation	wds:Q63111795-7EE190E0-78BE-4E4A-80FB-2359921BE6DF
employer	wds:Q63111795-C4AA958F-CCAF-4D69-96E1-FA9AD22D5480
sex or gender	wds:Q63111795-A3D4DBB4-10ED-4883-B8A2-B17EC4115D01
VIAF ID	wds:Q63111795-1ed3b7b4-4fdc-4c23-a5c5-d469959072eb
GND ID	wds:Q63111795-d172bd93-9737-45e0-80bd-39795eb825ed
educated at	wds:Q63111795-EC6F3042-D0B7-4412-B123-A61F8531FF78
VIAF ID	http://viaf.org/viaf/1840162181242808290001
GND ID	https://d-nb.info/gnd/1233807846
occupation	researcher
employer	University of Basel
sex or gender	male
VIAF ID	1840162181242808290001
GND ID	1233807846
educated at	University of Cologne
ORCID iD	wds:Q63111795-47275E7A-67B1-4F7D-AA11-138864119BB8
ORCID iD	https://orcid.org/0000-0003-4945-6511
ORCID iD	0000-0003-4945-6511
SNSF person ID	wds:Q63111795-510C8055-FABD-4DDE-9254-47B67984CEA5
SNSF person ID	94379
is owl:sameAs of	Thomas Klimkait
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q63111795
is author of	Ethnopharmacology in overdrive: the remarkable anti-HIV activity of Artemisia annua. Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy. Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients. African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study. Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study Promoter of FGF8 reveals a unique regulation by unliganded RARalpha Unusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strains The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types Viral Suppression Rates in Salvage Treatment With Raltegravir Improved With the Administration of Genotypic Partially Active or Inactive Nucleoside/Tide Reverse Transcriptase Inhibitors Clinical and socio-demographic predictors for virologic failure in rural Southern Africa: preliminary findings from CART-1. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion Contrary to HIV, hepatitis C virus is not associated with erythrocytes in vivo Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. Stable virulence levels in the HIV epidemic of Switzerland over two decades A prospective trial of structured treatment interruptions in human immunodeficiency virus infection Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations Rational optimization of a HIV-1 Tat inhibitor: rapid progress on combinatorial lead structures Assessing predicted HIV-1 replicative capacity in a clinical setting Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients Estimating the basic reproductive number from viral sequence data. Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure The role of compartment penetration in PI-Monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland Inferring epidemic contact structure from phylogenetic trees The XTrack system: application and advantage An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study Enhanced gene silencing by the application of multiple specific small interfering RNAs Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project Development of a simple microarray for genotyping HIV-1 drug resistance mutations in the reverse transcriptase gene in rural Tanzania Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A Determinants of HIV-1 broadly neutralizing antibody induction. A sensitive replicative system to assess HIV-1 drug resistance Alcohol use and depression: link with adherence and viral suppression in adult patients on antiretroviral therapy in rural Lesotho, Southern Africa: a cross-sectional study Prevalence of drug resistance mutations and HIV type 1 subtypes in an HIV type 1-infected cohort in rural Tanzania Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings? Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software